Disclosure Plus

HYTC Signs Trust Agreement to Acquire 5 Billion Won Worth of Treasury Stock

KIM YOON-JEONG
2026-06-05 13:18:10
[Edaily Reporter Kim Yoon-jung] #HYT announced on the 5th that it has entered into a trust agreement to acquire 5 billion won worth of its own shares to enhance shareholder value.
The contract period runs from the 10th of this month until June 9, 2027.

Economy

Corporation

IT·Science

Economy

Mixed Results for the Top Two Office Furniture Companies

Leading domestic office furniture companies— KOAS(071950)and Fursys(016800)—posted mixed first-half results. KOAS emerged from a prolonged period of losses by posting a first-half profit through cost-…
2026-08-19 07:13:42
[Market In] Subprime Bond Issuance Plummets 42%… BBB-Rated and Below Bonds Cut in Half
2026-08-19 07:06:05
"Europeans who stay in Korea for two weeks at a time will even venture out to the countryside if they can communicate in Korean:"
2026-08-19 06:00:06

Corporation

HEM Pharma Inc. Raises 54 Billion Won to Build New Sejong Plant No. 2... “Setting Sights on Global Markets, Including the U.S.”

#HEM Pharma Inc., a company specializing in microbiome healthcare, is accelerating the establishment of a key production hub targeting advanced global markets, including the U.S., after raising substa…
2026-08-18 17:40:03
'A First for K-Beauty': Chosun Beauty Enters Australian Supermarkets… Mamonde Expands into India
2026-08-18 17:19:55
From ‘Miwon’ to Pharmaceutical Ingredients… Daesang Accelerates Shift to High-Value-Added Materials Business
2026-08-18 16:50:47

IT·Science

JWPHARMACEUTICAL Goes Head-to-Head with 6mg ‘Gout Treatment’… Global Competition Also Accelerates

(Graphic: Generative AI) JWPHARMACEUTICAL(001060)’s new gout drug candidate, “Efamynurad,” has demonstrated its competitiveness at the 6 mg dose—its primary dosage—in a multinational Phase 3 clini…
2026-08-19 07:31:02
National AI Team Fails at ‘Point Allocation Design’… The Paradox of Motif’s Elimination Despite Topping the AAII Rankings [IT World Insights byKim Hyun-ah]
2026-08-18 16:44:45
ILDONG PHARM Group’s AIMS Establishes Support System for New Antimicrobial Drug Development… Resolving Development Bottlenecks
2026-08-18 16:34:02